Real-time enrollment status for this low testosterone clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 10:30 PM UTC
| NCT Number | NCT06689085 |
| Recruiting Status | Recruiting |
| Condition | Low Testosterone |
| Phase | PHASE3 |
| Target Enrollment | 100 participants |
| Active Locations | 20 sites in the US |
| Sponsor | Halozyme Therapeutics |
| Last Updated on CT.gov | February 18, 2026 (Feb 18, 2026) |
As of August 27, 2026: Clinical trial NCT06689085 is currently recruiting participants. This phase3 study for low testosterone is actively seeking new participants at 20 locations across the United States. The study is sponsored by Halozyme Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06689085 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06689085 was last updated Feb 18, 2026 (February 18, 2026). HelloStudys verifies this status automatically.